NCT01769144

Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh

Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh---A Randomised Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: Kaohsiung Veterans General Hospital. · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This study aims to compare the effectiveness of two wound dressings, Acticoat Absorbent (AA) and BCT Antimicrobial (BCT) on Split Thickness Skin Graft (STSG) donor site.

Detailed description

Seventy patients who undergo STSG procedure in Kaohsiung Veterans General Hospital will be recruited. Two donor sites of equal lengths and widths on the same thigh, which are at least 2 cm apart will be covered randomly with AA and BCT each. Wound healing rate and infection rate will be assessed at 7 and 14 days after surgery. Degrees of pain and itchiness will be assessed daily with Visual Analogue Scale for the first 7 post-operative days. Scar appearance will be assessed with Vancouver Scar Scale 1, 3 and 6 months post-operatively.

Conditions

• Wound Healing
• Wound Infection
• Pain
• Pruritus
• Cicatrix

Interventions

Type	Name	Description
DEVICE	Acticoat Absorbent	wound dressing
DEVICE	BCT	wound dressing

Timeline

• Start date: 2013-01-01
• Primary completion: 2013-07-01
• Completion: 2014-04-01
• First posted: 2013-01-16
• Last updated: 2013-02-21

Locations

1 site across 1 country: Taiwan